Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients.
Yvonne M GeurtsFemke PetersEsther FeldmanJeanine RoodhartMilan RichirJan Willem T DekkerGeerard BeetsJeltsje S CnossenPatricia BottenbergMartijn IntvenMarcel VerheijKelly M de LigtIris WalravenPublished in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2024)
Based on a comprehensive mixed methods study, a PRO-CTCAE subset for standardized treatment-related symptomatic toxicity monitoring in rectal cancer was identified. Assessment of the effectiveness and compliance of symptomatic toxicity monitoring using this subset is recommended.